These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1977451)

  • 1. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.
    Lamki LM; Patt YZ; Murray JL
    Cancer Treat Res; 1990; 51():293-312. PubMed ID: 1977451
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
    Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
    Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
    An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
    Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
    Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
    Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
    Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab' fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study.
    Lechner P; Lind P; Binter G; Cesnik H
    Dis Colon Rectum; 1993 Oct; 36(10):930-5. PubMed ID: 8404384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operative probe scintimetry with indium and technetium for colorectal cancer.
    Kuhn JA; Nochumson J
    J Surg Oncol; 2007 Sep; 96(4):290-6. PubMed ID: 17879338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody.
    Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G
    Rays; 1987; 12(1):67-71. PubMed ID: 3628863
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of radiolabeled antibody imaging on management of colon cancer.
    Beatty JD; Hyams DM; Morton BA; Beatty BG; Williams LE; Yamauchi D; Merchant B; Paxton RJ; Shively JE
    Am J Surg; 1989 Jan; 157(1):13-9. PubMed ID: 2910118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoscintigraphy of a colorectal tumor recurrence using a 99mTc-labeled anti-CEA-antibody].
    Rilinger N; Niemann H; Halbfass HJ
    Rontgenpraxis; 1989 Jul; 42(7):245-7. PubMed ID: 2756446
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoscintigraphy of colorectal carcinomas and recurrences with a technetium-99m-labeled monoclonal anti-CEA-antibody (MAB XBW 431/26).
    Lind P
    J Nucl Med; 1990 Apr; 31(4):535-6. PubMed ID: 2157833
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review.
    Buraggi GL; Gasparini M; Seregni E
    Int J Rad Appl Instrum B; 1991; 18(1):45-50. PubMed ID: 2010305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
    Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoscintigraphy of colorectal cancer with 111In labeled anti-CEA monoclonal antibody (ZCE-025)].
    Katayama M; Nakamura K; Hashimoto T; Tsukatani Y; Fujii H; Hashimoto J; Kubo A; Hashimoto S; Teramoto T; Kodaira S
    Kaku Igaku; 1991 Sep; 28(9):1057-65. PubMed ID: 1770658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab')2.
    Aprile C; Prati U; Saponaro R; Roveda L; Carena M; Gastaldo L
    Int J Rad Appl Instrum B; 1991; 18(1):51-2. PubMed ID: 2010306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
    Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
    Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
    Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
    Reiners C; Eilles C; Spiegel W; Becker W; Börner W
    Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.